Persistence of TEL-AML1 fusion gene as minimal residual disease has no additive prognostic value in CD 10 positive B-acute lymphoblastic leukemia: a FISH study

Email this article to a friend

Eman Mosad^*, Hosny B Hamed, Rania M Bakry, Azza M Ezz-Eldin and Nesrine M Khalifa

Journal of Hematology & Oncology 2008, 1:17 doi:10.1186/1756-8722-1-17